{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:52:00Z","timestamp":1785883920080,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74652-2","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:47:52Z","timestamp":1781956072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Choline metabolism drives metastasis in BRCA1-deficient ovarian cancers by activating FAM3C"],"prefix":"10.1038","volume":"17","author":[{"given":"Cong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dake","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8886-1873","authenticated-orcid":false,"given":"Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"74652_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).","journal-title":"Science"},{"key":"74652_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrc3162","volume":"11","author":"K Glunde","year":"2011","unstructured":"Glunde, K., Bhujwalla, Z. M. & Ronen, S. M. Choline metabolism in malignant transformation. Nat. Rev. Cancer 11, 835\u2013848 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"74652_CR3","doi-asserted-by":"publisher","first-page":"6556","DOI":"10.1038\/s41388-020-01456-z","volume":"39","author":"S Wen","year":"2020","unstructured":"Wen, S. et al. Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer. Oncogene 39, 6556\u20136571 (2020).","journal-title":"Oncogene"},{"key":"74652_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43378-w","volume":"14","author":"H Rao","year":"2023","unstructured":"Rao, H. et al. SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer. Nat. Commun. 14, 7572 (2023).","journal-title":"Nat. Commun."},{"key":"74652_CR5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209435120","volume":"120","author":"Q Ma","year":"2023","unstructured":"Ma, Q. et al. The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation. Proc. Natl. Acad. Sci. USA 120, e2209435120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74652_CR6","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.molcel.2021.05.005","volume":"81","author":"R Liu","year":"2021","unstructured":"Liu, R. et al. Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets. Mol. Cell 81, 2722\u20132735 e2729 (2021).","journal-title":"Mol. Cell"},{"key":"74652_CR7","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1038\/s41388-024-03150-w","volume":"43","author":"X Li","year":"2024","unstructured":"Li, X. et al. Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression. Oncogene 43, 3121\u20133136 (2024).","journal-title":"Oncogene"},{"key":"74652_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05291-w","volume":"13","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKalpha to disrupt choline metabolism. Cell Death Dis. 13, 845 (2022).","journal-title":"Cell Death Dis."},{"key":"74652_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Martinez-Reyes","year":"2021","unstructured":"Martinez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer 21, 669\u2013680 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"74652_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41586-019-1577-5","volume":"573","author":"JP Morris","year":"2019","unstructured":"Morris, J. P. et al. alpha-Ketoglutarate links p53 to cell fate during tumour suppression. Nature 573, 595\u2013599 (2019).","journal-title":"Nature"},{"key":"74652_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj, G. & Manning, B. D. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer 20, 74\u201388 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"74652_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","volume":"5","author":"Y Dong","year":"2020","unstructured":"Dong, Y., Tu, R., Liu, H. & Qing, G. Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat. Signal Transduct. Target. Ther. 5, 124 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"74652_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103350","volume":"76","author":"X Xie","year":"2024","unstructured":"Xie, X. et al. Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors. Redox Biol. 76, 103350 (2024).","journal-title":"Redox Biol."},{"key":"74652_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-024-07909-9","volume":"634","author":"I Ceppi","year":"2024","unstructured":"Ceppi, I. et al. Mechanism of BRCA1-BARD1 function in DNA end resection and DNA protection. Nature 634, 492\u2013500 (2024).","journal-title":"Nature"},{"key":"74652_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41586-023-06461-2","volume":"621","author":"J Setton","year":"2023","unstructured":"Setton, J. et al. Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. Nature 621, 129\u2013137 (2023).","journal-title":"Nature"},{"key":"74652_CR16","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1073\/pnas.171174298","volume":"98","author":"L Zheng","year":"2001","unstructured":"Zheng, L., Annab, L. A., Afshari, C. A., Lee, W. H. & Boyer, T. G. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc. Natl. Acad. Sci. USA 98, 9587\u20139592 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74652_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/embo-reports\/kvd059","volume":"1","author":"G Nadeau","year":"2000","unstructured":"Nadeau, G. et al. BRCA1 can stimulate gene transcription by a unique mechanism. EMBO Rep. 1, 260\u2013265 (2000).","journal-title":"EMBO Rep."},{"key":"74652_CR18","doi-asserted-by":"publisher","first-page":"24498","DOI":"10.1074\/jbc.M414020200","volume":"280","author":"LM Starita","year":"2005","unstructured":"Starita, L. M. et al. BRCA1\/BARD1 ubiquitinate phosphorylated RNA polymerase II. J. Biol. Chem. 280, 24498\u201324505 (2005).","journal-title":"J. Biol. Chem."},{"key":"74652_CR19","doi-asserted-by":"publisher","first-page":"10040","DOI":"10.1158\/0008-5472.CAN-08-3009","volume":"68","author":"T Xiang","year":"2008","unstructured":"Xiang, T. et al. Negative Regulation of AKT Activation by BRCA1. Cancer Res. 68, 10040\u201310044 (2008).","journal-title":"Cancer Res."},{"key":"74652_CR20","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1073\/pnas.1822155116","volume":"116","author":"S Verma","year":"2019","unstructured":"Verma, S. et al. BRCA1\/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling. Proc. Natl. Acad. Sci. USA 116, 7363\u20137370 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74652_CR21","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s43018-020-00139-8","volume":"1","author":"RM Samstein","year":"2021","unstructured":"Samstein, R. M. et al. Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy. Nat. Cancer 1, 1188\u20131203 (2021).","journal-title":"Nat. Cancer"},{"key":"74652_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109412","volume":"36","author":"M Bruand","year":"2021","unstructured":"Bruand, M. et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 36, 109412 (2021).","journal-title":"Cell Rep."},{"key":"74652_CR23","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1158\/0008-5472.CAN-14-1119","volume":"74","author":"F Bai","year":"2014","unstructured":"Bai, F. et al. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Res. 74, 6161\u20136172 (2014).","journal-title":"Cancer Res."},{"key":"74652_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41588-023-01298-x","volume":"55","author":"K Nee","year":"2023","unstructured":"Nee, K. et al. Preneoplastic stromal cells promote BRCA1-mediated breast tumorigenesis. Nat. Genet. 55, 595\u2013606 (2023).","journal-title":"Nat. Genet."},{"key":"74652_CR25","doi-asserted-by":"publisher","first-page":"15332","DOI":"10.1073\/pnas.0907864106","volume":"106","author":"CY Jao","year":"2009","unstructured":"Jao, C. Y., Roth, M., Welti, R. & Salic, A. Metabolic labeling and direct imaging of choline phospholipids in vivo. Proc. Natl. Acad. Sci. USA 106, 15332\u201315337 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74652_CR26","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112012","volume":"41","author":"M Wang","year":"2022","unstructured":"Wang, M., Chen, Z. & Zhang, Y. CBP\/p300 and HDAC activities regulate H3K27 acetylation dynamics and zygotic genome activation in mouse preimplantation embryos. EMBO J. 41, e112012 (2022).","journal-title":"EMBO J."},{"key":"74652_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20940-y","volume":"12","author":"Y Cai","year":"2021","unstructured":"Cai, Y. et al. H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions. Nat. Commun. 12, 719 (2021).","journal-title":"Nat. Commun."},{"key":"74652_CR28","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1158\/0008-5472.CAN-19-3934","volume":"80","author":"PJ Slavish","year":"2020","unstructured":"Slavish, P. J. et al. Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer. Cancer Res. 80, 3507\u20133518 (2020).","journal-title":"Cancer Res."},{"key":"74652_CR29","doi-asserted-by":"crossref","unstructured":"Gold, S. & Shilatifard, A. Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges. J. Clin. Investig. 134, e183391 (2024).","DOI":"10.1172\/JCI183391"},{"key":"74652_CR30","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1158\/1078-0432.CCR-21-3729","volume":"28","author":"MR Baer","year":"2022","unstructured":"Baer, M. R. et al. Phase I clinical trial of DNA methyltransferase inhibitor decitabine and PARP inhibitor talazoparib combination therapy in relapsed\/refractory acute myeloid leukemia. Clin. Cancer Res. 28, 1313\u20131322 (2022).","journal-title":"Clin. Cancer Res."},{"key":"74652_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35059-x","volume":"13","author":"A Verma","year":"2022","unstructured":"Verma, A. et al. EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis. Nat. Commun. 13, 7344 (2022).","journal-title":"Nat. Commun."},{"key":"74652_CR32","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/emboj.2013.95","volume":"32","author":"L Wang","year":"2013","unstructured":"Wang, L. et al. BRCA1 is a negative modulator of the PRC2 complex. EMBO J. 32, 1584\u20131597 (2013).","journal-title":"EMBO J."},{"key":"74652_CR33","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir, B., Chiarella, A. M., Pitarresi, J. R. & Rustgi, A. K. EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol. 30, 764\u2013776 (2020).","journal-title":"Trends Cell Biol."},{"key":"74652_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/17460441.2018.1426567","volume":"13","author":"E Magnotti","year":"2018","unstructured":"Magnotti, E. & Marasco, W. A. The latest animal models of ovarian cancer for novel drug discovery. Expert Opin. Drug Discov. 13, 249\u2013257 (2018).","journal-title":"Expert Opin. Drug Discov."},{"key":"74652_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ccr.2006.07.020","volume":"10","author":"T Waerner","year":"2006","unstructured":"Waerner, T. et al. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell 10, 227\u2013239 (2006).","journal-title":"Cancer Cell"},{"key":"74652_CR36","doi-asserted-by":"publisher","first-page":"26014","DOI":"10.1074\/jbc.M601960200","volume":"281","author":"A Valeva","year":"2006","unstructured":"Valeva, A. et al. Evidence that clustered phosphocholine head groups serve as sites for binding and assembly of an oligomeric protein pore. J. Biol. Chem. 281, 26014\u201326021 (2006).","journal-title":"J. Biol. Chem."},{"key":"74652_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopha.2017.10.101","volume":"97","author":"GJ Khan","year":"2018","unstructured":"Khan, G. J. et al. Pharmacological effects and potential therapeutic targets of DT-13. Biomed. Pharmacother. 97, 255\u2013263 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"74652_CR38","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1200\/JCO.21.02112","volume":"40","author":"S Li","year":"2022","unstructured":"Li, S. et al. Cancer risks associated with BRCA1 and BRCA2 pathogenic variants. J. Clin. Oncol. 40, 1529\u20131541 (2022).","journal-title":"J. Clin. Oncol."},{"key":"74652_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201903616","volume":"7","author":"Q Chen","year":"2020","unstructured":"Chen, Q. et al. BRCA1 deficiency impairs mitophagy and promotes inflammasome activation and mammary tumor metastasis. Adv. Sci. 7, 1903616 (2020).","journal-title":"Adv. Sci."},{"key":"74652_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102356","volume":"54","author":"Y Kong","year":"2022","unstructured":"Kong, Y. et al. BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance. Redox Biol. 54, 102356 (2022).","journal-title":"Redox Biol."},{"key":"74652_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00407-z","volume":"8","author":"HR Garber","year":"2022","unstructured":"Garber, H. R. et al. Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer. npj Breast Cancer 8, 46 (2022).","journal-title":"npj Breast Cancer"},{"key":"74652_CR42","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/sj.onc.1205144","volume":"21","author":"A Ramirez de Molina","year":"2002","unstructured":"Ramirez de Molina, A., Penalva, V., Lucas, L. & Lacal, J. C. Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K. Oncogene 21, 937\u2013946 (2002).","journal-title":"Oncogene"},{"key":"74652_CR43","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/j.1471-4159.2008.05681.x","volume":"107","author":"B Madziar","year":"2008","unstructured":"Madziar, B. et al. Nerve growth factor regulates the expression of the cholinergic locus and the high-affinity choline transporter via the Akt\/PKB signaling pathway. J. Neurochem. 107, 1284\u20131293 (2008).","journal-title":"J. Neurochem."},{"key":"74652_CR44","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08975","volume":"464","author":"RA Gupta","year":"2010","unstructured":"Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071\u20131076 (2010).","journal-title":"Nature"},{"key":"74652_CR45","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/0008-5472.CAN-21-0914","volume":"82","author":"L Ippolito","year":"2022","unstructured":"Ippolito, L. et al. Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer. Cancer Res. 82, 1267\u20131282 (2022).","journal-title":"Cancer Res."},{"key":"74652_CR46","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez, M., Urdiroz-Urricelqui, U., Bigas, C. & Benitah, S. A. The role of lipids in cancer progression and metastasis. Cell Metab. 34, 1675\u20131699 (2022).","journal-title":"Cell Metab."},{"key":"74652_CR47","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41586-022-04758-2","volume":"605","author":"M Rossi","year":"2022","unstructured":"Rossi, M. et al. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. Nature 605, 747\u2013753 (2022).","journal-title":"Nature"},{"key":"74652_CR48","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1016\/j.molcel.2022.06.005","volume":"82","author":"D He","year":"2022","unstructured":"He, D. et al. Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. Mol. Cell 82, 3045\u20133060.e11 (2022).","journal-title":"Mol. Cell"},{"key":"74652_CR49","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41418-024-01402-6","volume":"31","author":"L Lanzetti","year":"2024","unstructured":"Lanzetti, L. Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer. Cell Death Differ. 31, 1582\u20131594 (2024).","journal-title":"Cell Death Differ."},{"key":"74652_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.453","volume":"4","author":"E Sanchez-Lopez","year":"2013","unstructured":"Sanchez-Lopez, E. et al. Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via CHOP in cancer cells. Cell Death Dis. 4, e933 (2013).","journal-title":"Cell Death Dis."},{"key":"74652_CR51","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1053\/j.gastro.2016.12.033","volume":"152","author":"XM Lin","year":"2017","unstructured":"Lin, X. M. et al. Choline kinase alpha mediates interactions between the epidermal growth factor receptor and mechanistic target of rapamycin complex 2 in hepatocellular carcinoma cells to promote drug resistance and xenograft tumor progression. Gastroenterology 152, 1187\u20131202 (2017).","journal-title":"Gastroenterology"},{"key":"74652_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113511","volume":"42","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. Oncogenic KRAS effector USP13 promotes metastasis in non-small cell lung cancer through deubiquitinating beta-catenin. Cell Rep. 42, 113511 (2023).","journal-title":"Cell Rep."},{"key":"74652_CR53","doi-asserted-by":"publisher","first-page":"26580","DOI":"10.1073\/pnas.1911273116","volume":"116","author":"E Driehuis","year":"2019","unstructured":"Driehuis, E. et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc. Natl. Acad. Sci. USA 116, 26580\u201326590 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74652_CR54","doi-asserted-by":"publisher","first-page":"e0245962","DOI":"10.1371\/journal.pone.0245962","volume":"16","author":"JD Baker","year":"2021","unstructured":"Baker, J. D., Uhrich, R. L., Kraemer, G. C., Love, J. E. & Kraemer, B. C. A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease. PLoS ONE 16, e0245962 (2021).","journal-title":"PLoS ONE"},{"key":"74652_CR55","doi-asserted-by":"crossref","unstructured":"Yin, X. R. et al. A novel CXCR4-targeted peptide for SPECT\/CT imaging in tumor. Sens. Actuators B Chem. 410, 135595 (2024).","DOI":"10.1016\/j.snb.2024.135595"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74652-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:24:13Z","timestamp":1785882253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74652-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74652"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74652-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7786"}}